GADICKE ANSBERT
SEC insider (Form 3/4/5 filer). CIK 0001134655. 10% Owner at Aktis Oncology, Inc. (AKTS) and 2 other issuers. 35 reported Form 4/5 transactions since Sep 2024; latest on Jan 12, 2026. Located in BOSTON, MA.
Companies GADICKE ANSBERT has filed insider reports for
- Aktis Oncology, Inc. (AKTS): 10% Owner
- Werewolf Therapeutics, Inc. (HOWL): 10% Owner
- iTeos Therapeutics, Inc. (ITOS)
GADICKE ANSBERT
CIK: 0001134655
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (35 total)
- Jan 12, 2026AKTS
Aktis Oncology, Inc.
PurchaseIndirect1.1M shares at avg. $18.00$20.0M - Jan 12, 2026AKTS
Aktis Oncology, Inc.
ConversionIndirect5.9M shares- - Jan 12, 2026AKTS
Aktis Oncology, Inc.
ConversionIndirect1.6M shares- - Jan 12, 2026AKTS
Aktis Oncology, Inc.
ConversionIndirect1.3M shares- - Dec 4, 2025HOWL
Werewolf Therapeutics, Inc.
SaleIndirect83.2K shares at avg. $0.97$81K - Dec 3, 2025HOWL
Werewolf Therapeutics, Inc.
SaleIndirect57.2K shares at avg. $0.87$50K - Dec 2, 2025HOWL
Werewolf Therapeutics, Inc.
SaleIndirect59.3K shares at avg. $0.89$53K - Dec 1, 2025HOWL
Werewolf Therapeutics, Inc.
SaleIndirect60.9K shares at avg. $0.94$57K - Nov 28, 2025HOWL
Werewolf Therapeutics, Inc.
SaleIndirect20.3K shares at avg. $0.99$20K - Nov 26, 2025HOWL
Werewolf Therapeutics, Inc.
SaleIndirect60.7K shares at avg. $0.98$60K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 12, 2026 |  AKTS Aktis Oncology, Inc. | Purchase | 1,112,777 | $18.00 | $20,029,986 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion | 5,914,197 | - | $0 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion | 1,577,119 | - | $0 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion | 1,314,262 | - | $0 | Indirect |
| Dec 4, 2025 |  HOWL Werewolf Therapeutics, Inc. | Sale | 83,230 | $0.97 | $80,733 | Indirect |
| Dec 3, 2025 | HOWL Werewolf Therapeutics, Inc. | Sale | 57,225 | $0.87 | $49,786 | Indirect |
| Dec 2, 2025 | HOWL Werewolf Therapeutics, Inc. | Sale | 59,277 | $0.89 | $52,757 | Indirect |
| Dec 1, 2025 | HOWL Werewolf Therapeutics, Inc. | Sale | 60,917 | $0.94 | $57,262 | Indirect |
| Nov 28, 2025 | HOWL Werewolf Therapeutics, Inc. | Sale | 20,277 | $0.99 | $20,074 | Indirect |
| Nov 26, 2025 | HOWL Werewolf Therapeutics, Inc. | Sale | 60,733 | $0.98 | $59,518 | Indirect |
1-10 of 35 transactions